Literature DB >> 1372429

Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures.

E G Jones1, M E Harper.   

Abstract

Short term explant cultures of benign prostatic hyperplasia (BPH) tissues were studied immunohistochemically to characterise both the morphological changes within the explant tissue and the cellular origin of the epithelial cell outgrowth. Altered patterns of expression of cytokeratins, prostate specific antigen (PSA) prostatic acid phosphatase (PAP), and epidermal growth factor (EGF) receptor were observed. After sloughing of the secretory epithelium in the majority of the acini repopulation and outgrowth of a monolayer was accomplished by cells which were strongly positive for stratifying keratin and EGF receptor and negative for PAP and PSA, indicative of a basal cell phenotype. The peak of proliferation in the acini, as assessed by Ki-67 immunohistochemistry, occurred after 2-4 days in culture. Preliminary studies on BPH tissue xenografts in nude mice indicated that better preservation of normal morphology, secretory activity, and antigen expression could be achieved.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372429     DOI: 10.1002/pros.2990200209

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.

Authors:  Y Yang; J Hao; X Liu; B Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  p63 is a prostate basal cell marker and is required for prostate development.

Authors:  S Signoretti; D Waltregny; J Dilks; B Isaac; D Lin; L Garraway; A Yang; R Montironi; F McKeon; M Loda
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation.

Authors:  Pinuccia Faviana; Beatrice Belgio; Marco Panichi; Francesca Manassero; Cesare Selli; Laura Boldrini
Journal:  Urol Ann       Date:  2022-04-18

Review 4.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates.

Authors:  S Claus; M Wrenger; T Senge; H Schulze
Journal:  Urol Res       Date:  1993

Review 6.  Etiology: where does prostatitis stop and interstitial cystitis begin?

Authors:  Evan R Eisenberg; Robert M Moldwin
Journal:  World J Urol       Date:  2003-05-28       Impact factor: 4.226

Review 7.  Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.

Authors:  E R Sherwood; C Lee
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 8.  Ex vivo culture of human prostate tissue and drug development.

Authors:  Margaret M Centenera; Ganesh V Raj; Karen E Knudsen; Wayne D Tilley; Lisa M Butler
Journal:  Nat Rev Urol       Date:  2013-06-11       Impact factor: 14.432

9.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

Authors:  S W Hayward; R Dahiya; G R Cunha; J Bartek; N Deshpande; P Narayan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

Review 10.  Similarities between interstitial cystitis and male chronic pelvic pain syndrome.

Authors:  Robert M Moldwin
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.